The oncology pharma market has largely been dominated by European and U.S. companies. With the ongoing expansion of the Chinese biopharma sector, innovative oncology drugs will emerge from China and compete on the international market.
- Developing A Process Performance Qualification Master Plan For Gene Therapies
- What Time Is Best To Bring My CDMO On Board?
- Cell & Gene Therapies: An Overview Of FDA Regulatory Considerations For 2024
- How To Determine Country Feasibility For Cell And Gene Therapy Clinical Trials
- Unpacking The Importance Of Lipid Nanoparticle Production Platforms
- Cell Counting Is Growing More Important Amid Advanced Therapy’s Rise
- Reducing the Disease Burden of AML with Vor Bio's Dr. Robert Ang
- 2024 CIO Survey Reveals IT Budgets, AI Priorities For Life Sciences Companies
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Optimizing Washing Efficiency In Cell Washing And Media Exchange
Review data collected on the performance of a single-use centrifuge in cell washing that demonstrates how it can help cell therapy manufacturers using a closed system.
-
Explore Protein Interactions Beyond Affinity To Boost Your Academic Research
Explore how you can simplify research on protein-protein interactions using our SPR systems.
-
AAV Production In Suspension HEK293 Cells With Single-Use Bioreactors
Explore how we expanded HEK293/HEK293T suspension cells from small cell culture (20 mL) in shake flasks up to a 10 L culture in a benchtop Xcellerex™ XDR-10 single-use bioreactor system.
-
Automated High-Throughput Osmolality Testing With Precision And Accuracy
Maintain confidence in decision making early in the bioprocess to ensure a safe and effective drug product further down the line.
-
Natural Killer Cells Manufacturing
Follow the feasibility of xeno‑free NK cell expansion, closure of key unit operations, and how future work could focus on fine‑tuning each step to generate a robust, scalable process.
-
Accelerating Bulk Harvest Testing Using A CHO Animal Origin Free Virus Panel
Here, we describe the design and performance of a degenerate PCR-based approach to broad virus screening that can be used in testing bulk harvest material derived from CHO cells.
-
Enhance Your TIL Expansion
Learn how organoids can aid in the evaluation of TIL-tumor cell interactions and facilitate the comparison of expansion media.
-
CHO Culture: Bioprocess Modes Batch Fed-Batch and Perfusion
Explore the differences between three cell culture bioprocesses using bench-scale CHO cells, and why tracking specific parameters is important to achieving the inoculation of bioreactors at high viability.
-
Data Utilization For Advanced Analytics And Near Real-Time Monitoring
Control, monitor, and analyze equipment, processes, results, and data in near real time and make data-driven decisions at both the process and plant levels.
-
A Framework For Controlling Variability And Optimizing Assay Performance
By employing a process optimization approach to assay development, you can improve overall assay performance.
NEWSLETTER ARCHIVE
- 04.23.24 -- Inside Tenaya Therapeutics' AAV9-Based Gene Therapy
- 04.22.24 -- Novel Approaches In Chromatography Process Development
- 04.22.24 -- 4 RNA Engineering Trends To Watch
- 04.18.24 -- Optimizing Drug Delivery Systems For Complex Biologics
- 04.18.24 -- The Role Of Behavioral Science In Improving CGT Adoption
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections